Bevacizumab Effect on Blood Velocity

Optical Imaging, Ltd.12 enrolled

Overview

Retinal blood flow velocity is affected by Bevacizump intravitreal injection. This effect is correlated to treatment success.

The purpose of the study was to carry out a pilot study on the short-term effect of intravitreal Bevacizumab (Avastin) injection on retinal blood-flow velocity and test whether the short-term haemodynamic changes could predict the longer term clinical result of the treatment.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Choroidal Neovascularization

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with CNV receiving Bevacizumab intravitreal injection Exclusion Criteria: * Candidates in whom the retina could not be seen clearly because of media opacity or a poorly dilating pupil

Locations (1)

Tel aviv sourasky medical center

Tel Aviv, Israel

Outcomes

Primary Outcomes

Blood flow velocity change

Time frame: 1 day following injection

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.